Baseline plasma IL-18 may predict simvastatin treatment response in patients with ARDS: a secondary analysis of the HARP-2 randomised clinical trial. (2022)
Attributed to:
Hydroxymethylglutaryl-CoA reductase inhibition with simvastatin in Acute lung injury to Reduce Pulmonary dysfunctio
funded by
MRC
Abstract
No abstract provided
Bibliographic Information
Digital Object Identifier: http://dx.doi.org/10.1186/s13054-022-04025-w
PubMed Identifier: 35672834
Publication URI: http://europepmc.org/abstract/MED/35672834
Type: Journal Article/Review
Volume: 26
Parent Publication: Critical care (London, England)
Issue: 1
ISSN: 1364-8535